Viewing Study NCT03442556

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:15 PM
Ignite Modification Date: 2026-01-02 @ 2:50 AM
Study NCT ID: NCT03442556
Status: TERMINATED
Last Update Posted: 2025-06-12
First Post: 2018-02-09
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency
Sponsor: University of Washington
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None ATM Gene Mutation View
None BRCA1 Gene Mutation View
None BRCA2 Gene Mutation View
None Castration Levels of Testosterone View
None Castration-Resistant Prostate Carcinoma View
None Homologous Recombination Deficiency View
None Prostate Carcinoma Metastatic in the Bone View
None PSA Level Greater Than or Equal to Two View
None PSA Progression View
None Stage IV Prostate Adenocarcinoma AJCC v7 View
Keywords: